Advertisement

Chinese Journal of Integrative Medicine

, Volume 25, Issue 10, pp 723–727 | Cite as

Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke

  • Yong-hua ZhaoEmail author
Feature Article
  • 11 Downloads

Abstract

Ischemic stroke accounts for the majority of all strokes and has been primary causes of long-term disability and mortality in worldwide. Mesenchymal stem cell (MSC) therapy suggests significantly improved effects on neurological functional outcome, neurogenesis, angiogenesis, blood-brain barrier permeability, inflammatory injury, neuroprotection and so on, following stroke. However, the occurrence of adverse effects results in restriction of the therapy. Chinese medicine accumulates abundant clinical experiences on stroke for over two thousand years, and some formulae and active ingredients of Chinese medicines have presented obvious efficacies in clinical treatment. Therefore, based on Chinese medicine theory, we provide some ideas of screening agents for combination treatment of Chinese medicines and MSC for ischemic stroke, and summarize the potentials of Chinese medicines in MSC treatment and analyze the feasibilities of Chinese medicines against side effects of MSC therapy. Consequently, we propose Chinese medicines combing with MSC should be a promising approach to clinical stroke treatment in future.

Keywords

Chinese medicines combination treatment ischemic stroke mesenchymal stem cell 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, incidence, and mortality of stroke in China: Results from a nationwide population-based survey of 480,687 adults. Circulation 2017;135:759–771.CrossRefGoogle Scholar
  2. 2.
    Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al. American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2016;47:581–641.CrossRefGoogle Scholar
  3. 3.
    Janowski M, Wagner DC, Boltze J. Stem cell-based tissue replacement after stroke: Factual necessity or notorious fiction?. Stroke 2015;46:2354–2363.CrossRefGoogle Scholar
  4. 4.
    Wang F, Tang H, Zhu J, Zhang JH. Transplanting mesenchymal stem cells for treatment of ischemic stroke. Cell Transplant 2018;27:1825–1834.CrossRefGoogle Scholar
  5. 5.
    Bhasin A, Kumaran SS, Bhatia R, Mohanty S, Srivastava MVP. Safety and feasibility of autologous mesenchymal stem cell transplantation in chronic stroke in Indian patients. A fouryear follow up. J Stem Cells Regen Med 2017;13:14–19.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and metaanalysis of clinical trials. PLoS One 2012;7:e47559.CrossRefGoogle Scholar
  7. 7.
    Boltze J, Arnold A, Walczak P, Jolkkonen J, Cui L, Wagner DC. The dark side of the force-constraints and complications of cell therapies for stroke. Front Neurol 2015;6:155.CrossRefGoogle Scholar
  8. 8.
    Incontri Abraham D, Gonzales M, Ibarra A, Borlongan CV. Stand alone or join forces? stem cell therapy for stroke. Expert Opin Biol Ther 2018. doi:  https://doi.org/10.1080/14712598.2019.1551872.Google Scholar
  9. 9.
    Si YC, Li Q, Xie CE, Niu X, Xia XH, Yu CY. Chinese herbs and their active ingredients for activating xue (blood) promote the proliferation and differentiation of neural stem cells and mesenchymal stem cells. Chin Med 2014;9:13.CrossRefGoogle Scholar
  10. 10.
    Hu XY, Wang WX, Yu MJ, Liu XB, Wu RR, Gao F, et al. Tongxinluo promotes mesenchymal stem cell tube formation in vitro. J Zhejiang Univ Sci B 2011;12:644–651.CrossRefGoogle Scholar
  11. 11.
    Zheng XW, Yang WT, Chen S, Xu QQ, Shan CS, Zheng GQ, et al. Neuroprotection of catalpol for experimental acute focal ischemic stroke: Preclinical evidence and possible mechanisms of antioxidation, anti-inflammation, and antiapoptosis. Oxid Med Cell Longev 2017;2017:5058609.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Ju X, Xue D, Wang T, Ge B, Zhang Y, Li Z. Catalpol promotes the survival and VEGF secretion of bone marrow-derived stem cells and their role in myocardial repair after myocardial infarction in rats. Cardiovasc Toxicol 2018;18:471–481.CrossRefGoogle Scholar
  13. 13.
    Zhang XG, Shan C, Zhu JZ, Bao XY, Tong Q, Wu XF, et al. Additive neuroprotective effect of borneol with mesenchymal stem cells on ischemic stroke in mice. Front Physiol 2018;8:1133.CrossRefGoogle Scholar
  14. 14.
    Xia XH, Li Q, Liu M. Neuroprotective effect of a formula, moschus combined with borneolum synthcticum, from traditional Chinese medicine on ischemia stroke in rats. Evid Based Complement Alternat Med 2014;2014:157938.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Song J, Chen X, Lyu Y, Zhuang W, Zhang J, Gao L, et al. Sanhuang Xiexin Decoction promotes good functional outcome in acute ischemic stroke. Brain Behav 2019;9:e01185.CrossRefGoogle Scholar
  16. 16.
    Li W, Liu Y, Wang B, Luo Y, Hu N, Chen D, et al. Protective effect of berberine against oxidative stress-induced apoptosis in rat bone marrow-derived mesenchymal stem cells. Exp Ther Med 2016;12:4041–4048.CrossRefGoogle Scholar
  17. 17.
    Kim R, Kim P, Lee CY, Lee S, Yun H, Lee MY, et al. Multiple combination of Angelica gigas extract and mesenchymal stem cells enhances therapeutic effect. Biol Pharm Bull 2018;41:1748–1756.CrossRefGoogle Scholar
  18. 18.
    Oh TW, Park KH, Jung HW, Park YK. Neuroprotective effect of the hairy root extract of Angelica gigas NAKAI on transient focal cerebral ischemia in rats through the regulation of angiogenesis. BMC Complement Altern Med 2015;15:101.CrossRefGoogle Scholar
  19. 19.
    Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003;17:1943–1944.CrossRefGoogle Scholar
  20. 20.
    Zhu L, Liu YJ, Shen H, Gu PQ, Zhang L. Astragalus and Baicalein regulate inflammation of mesenchymal stem cells (MSCs) by the mitogen-activated protein kinase (MAPK)/ERK pathway. Med Sci Monit 2017;23:3209–3216.CrossRefGoogle Scholar
  21. 21.
    Zheng XW, Shan CS, Xu QQ, Wang Y, Shi YH, Wang Y, et al. Buyang Huanwu Decoction targets SIRT1/VEGF pathway to promote angiogenesis after cerebral ischemia/reperfusion injury. Front Neurosci 2018;12:911.CrossRefGoogle Scholar
  22. 22.
    Yang J, Gao F, Zhang Y, Liu Y, Zhang D. Buyang Huanwu Decoction (BYHWD) enhances angiogenic effect of mesenchymal stem cell by up-regulating VEGF expression after focal cerebral ischemia. J Mol Neurosci 2015;56:898–906.CrossRefGoogle Scholar
  23. 23.
    Xie J, Wang H, Song T, Wang Z, Li F, Ma J, et al. Tanshinone ?A and astragaloside ? promote the migration of mesenchymal stem cells by up-regulation of CXCR4. Protoplasma 2013;250:521–530.CrossRefGoogle Scholar
  24. 24.
    Zhao YH, Liu NW, Ke CC, Liu BW, Chen YA, Luo C, et al. Combined treatment of sodium ferulate, n-butylidenephthalide, and ADSCs rehabilitates neurovascular unit in rats after photothrombotic stroke. J Cell Mol Med 2019;23:126–142.CrossRefGoogle Scholar
  25. 25.
    Yang Q, Jia YJ, Yang J. Effect of nuclear factor-kappaB on differentiation of bone marrow stromal cells into neurons induced by baicalin in rats. Chin J Integr Tradit West Med (Chin) 2005;25:248–251.Google Scholar
  26. 26.
    Wang Y, Deng Z, Lai X, Tu W. Differentiation of human bone marrow stromal cells into neural-like cells induced by sodium ferulate in vitro. Cell Mol Immunol 2005;2:225–229.PubMedGoogle Scholar
  27. 27.
    Zhao Y, Lai W, Xu Y, Li L, Chen Z, Wu W. Exogenous and endogenous therapeutic effects of combination Sodium Ferulate and bone marrow stromal cells (BMSCs) treatment enhance neurogenesis after rat focal cerebral ischemia. Metab Brain Dis 2013;28:655–666.CrossRefGoogle Scholar
  28. 28.
    Zhang Q, Zhao Y, Xu Y, Chen Z, Liu N, Ke C, et al. Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemia. J Transl Med 2016;14:223.CrossRefGoogle Scholar
  29. 29.
    Zhang Q, Chen ZW, Zhao YH, Liu BW, Liu NW, Ke CC, et al. Bone marrow stromal cells combined With sodium ferulate and n-butylidenephthalide promote the effect of therapeutic angiogenesis via advancing astrocyte-derived trophic factors after ischemic stroke. Cell Transplant 2017;26:229–242.CrossRefGoogle Scholar
  30. 30.
    Scheibe F, Ladhoff J, Huck J, Grohmann M, Blazej K, Oersal A, et al. Immune effects of mesenchymal stromal cells in experimental stroke. J Cereb Blood Flow Metab 2012;32:1578–1588.CrossRefGoogle Scholar
  31. 31.
    Smith CJ, Denes A, Tyrrell PJ, Di Napoli M. Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke. Expert Opin Investig Drugs 2015;24:623–643.CrossRefGoogle Scholar
  32. 32.
    Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 2011;42:3551–3558.CrossRefGoogle Scholar
  33. 33.
    Zhang JS, Zhang BX, Du MM, Wang XY, Li W. Chinese preparation Xuesaitong promotes the mobilization of bone marrow mesenchymal stem cells in rats with cerebral infarction. Neural Regen Res 2016;11:292–297.CrossRefGoogle Scholar
  34. 34.
    Wei SG, Meng LQ, Huang RY. Effect of Panax notoginseng saponins on serum neuronal specific enolase and rehabilitation in patients with cerebral hemorrhage. Chin J Integr Tradit West Med (Chin) 2007;27:159–162.Google Scholar
  35. 35.
    Cui LL, Kerkelä E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther 2015;6:11.CrossRefGoogle Scholar
  36. 36.
    Liu L, Liu JX, Guo H, Ren JX. Recent advances on pericytes in microvascular dysfunction and traditional Chinese medicine prevention. China J Chin Mater Med (Chin) 2017;42:3072–3077.Google Scholar
  37. 37.
    Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 2014;508:55–60.CrossRefGoogle Scholar
  38. 38.
    Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng 2019;3:90–104.CrossRefGoogle Scholar

Copyright information

© The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical SciencesUniversity of MacauMacaoChina

Personalised recommendations